NEW YORK, March 24 (GenomeWeb News) - MWG Biotech will supply Pfizer with sequencing services, microarrays, and oligonucleotides, the company said today.


Under a new worldwide framework agreement, MWG Biotech of Ebersberg, Germany, will be Pfizer's "Partner of Choice" for these products and services. The agreement is non-exclusive and unlimited, according to an MWG spokeswoman.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.